Bird Rock Bio's Gerilimzumab, an Anti-IL-6 Antibody, Demonstrates Potential …

Bird Rock Bio's Gerilimzumab, an Anti-IL-6 Antibody, Demonstrates Potential …

With more than 20 million rheumatoid arthritis patients globally, many of whom do not have access to the most advanced therapies, gerilimzumab represents a tremendous opportunity for innovation to provide affordable access to a best-in-class therapy …

(Visited 1 times, 1 visits today)
2
Like
Save

Comments

Comments are disabled for this post.